CrossrefInfokarte
Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings
Journal of the American Medical Directors Association · 2026-11 · 27 (11) · 106406
DOI: 10.1016/j.jamda.2026.106406 ↗Abstract
Kein Abstract verfügbar.
EUVIMED